This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Treatment of RSV

Authoring team

Treatment is largely symptomatic.

Main aim of management is to maintain hydration and oxygenation (1).

  • dehydration in children with bronchiolitis may occur secondary to increased respiratory rate, fever, and poor feeding caused by difficulty breathing and nasal secretions.
    • IV fluids should be considered in infants with severe respiratory difficulty, a respiratory rate greater than 80 breaths per minute, or those who visibly tire during feeding
  • intubation and ventilatory assistance are given if there is severe hypoxia
  • humidified oxygen may be required if arterial oxygen tension is low.
    • should be used in children with saturations below 90 %

A single trial of a bronchodilator may be useful in children with wheezing but routine use is not recommended (1).

Corticosteroids (oral and inhaled) may be useful in older children with a history of asthma (1).

Ribavarin, a nucleoside analogue which is active in vitro against RSV, has been shown to relieve lower respiratory tract illness in children.

  • it is used by inhalation since oral administration is associated with liver and bone marrow toxicity
  • not recommended for routine use, reserved for immunosuppressed children with severe RSV infection (1)
  • studies have yet to be conducted in adults

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page